ArticleBMC medical imaging2026
Carotid body measurement by computed tomography angiography: a cross-sectional population-based study.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCarotid bodies (CBs) are chemoreceptors located at the bifurcation of the common carotid arteries, playing an essential role in maintaining blood gas homeostasis and regulating cardiovascular function. CBs are increasingly affected in various systemic pathologies, particularly those involving sympathetic overactivation, including hypertension and heart failure. Despite CB hypertrophy in these conditions has been well-studied, normative data on dimensions remain scarce. This study aimed to establish reference ranges for CB size in a large Iranian population using computed tomography angiography (CTA).
methodsA cross-sectional study of 650 patients who underwent neck CTA (April 2023-April 2025) was conducted. After excluding 36 patients with carotid body tumors and further removing cases with missing, unmeasurable, or outlier measurements, 521 patients were included for final analysis. CB dimensions were measured in both the transverse (R1) and anteroposterior (R2) planes. Reference ranges were calculated and stratified by age, sex, and comorbidity status. In addition, subgroup analysis was performed to examine the influence of chronic diseases including hypertension, diabetes mellitus, hyperlipidemia, cardiovascular disease, chronic obstructive pulmonary diseases, cerebrovascular accident/transient ischemic attack (CVA/TIA), and thyroid disease.
resultsIn this study, the mean R1 of the CB was 2.66 ± 0.5 mm, and the mean R2 was 3.25 ± 0.61 mm. Notable size variations were observed across age groups, with the 60-70 years group showing a marginally significant larger R1 of 2.96 ± 0.45 mm and R2 of 3.54 ± 0.51 mm (p-value = 0.070). No statistically significant differences were observed across sex categories. Also, participants with chronic diseases exhibited slightly larger CBs compared to those without (R1 = 2.71 ± 1.20 vs. 2.57 ± 0.52, p-value = 0.128 and R2 = 3.30 ± 1.34 vs. 3.17 ± 0.63, p-value = 0.204, respectively).
conclusionsThis study provides a comprehensive reference ranges for CB dimensions in a general population, with specific subranges based on age, sex, and comorbidities. These findings can enhance diagnostic accuracy and help distinguish between normal CB enlargement and pathological conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.